Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wergeland

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
European Journal of Neurology|August 23, 2018
Response to 'Seasonal variation of vitamin D and Epstein-Barr virus antibody in multiple sclerosis patients', a comment letter regarding 'Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients'S Wergeland, T Riise, Ø Torkildsen
Acta Neurologica Scandinavica. Supplementum|January 3, 2013
Polyunsaturated fatty acids in multiple sclerosis therapyS Wergeland, Ø Torkildsen, L Bø, et al.
Acta Neurologica Scandinavica. Supplementum|November 30, 2012
Fat-soluble vitamins as disease modulators in multiple sclerosisØ Torkildsen, K I Løken-Amsrud, S Wergeland, et al.
Acta Neurologica Scandinavica|June 6, 2015
The Norwegian Multiple Sclerosis Registry and BiobankK-M Myhr, N Grytten, Ø Torkildsen, et al.
Acta Neurologica Scandinavica. Supplementum|January 3, 2013
A need for national registries and international collaborative research in multiple sclerosisK M Myhr, N Grytten, Ø Torkildsen, et al.
Journal of Neurology|December 14, 2023
Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based studyA Habbestad, J S Willumsen, J H Aarseth, et al.
European Journal of Neurology|February 8, 2005
IL-10 promoter haplotype influence on interferon treatment response in multiple sclerosisS Wergeland, A Beiske, H Nyland, et al.
Acta Neurologica Scandinavica|June 4, 2015
WT1 and interferon-β-vitamin D association in MS: a longitudinal studyT Holmøy, Q Y Esbensen, Ø Torkildsen, et al.
European Journal of Neurology|March 22, 2016
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patientsS Wergeland, K-M Myhr, K I Løken-Amsrud, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 15, 2015
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre studyJ Kuhle, G Disanto, R Dobson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Journal of Neurology|August 23, 2018
Response to 'Seasonal variation of vitamin D and Epstein-Barr virus antibody in multiple sclerosis patients', a comment letter regarding 'Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients'S Wergeland, T Riise, Ø Torkildsen
Acta Neurologica Scandinavica. Supplementum|January 3, 2013
Polyunsaturated fatty acids in multiple sclerosis therapyS Wergeland, Ø Torkildsen, L Bø, et al.
Acta Neurologica Scandinavica. Supplementum|November 30, 2012
Fat-soluble vitamins as disease modulators in multiple sclerosisØ Torkildsen, K I Løken-Amsrud, S Wergeland, et al.
Acta Neurologica Scandinavica|June 6, 2015
The Norwegian Multiple Sclerosis Registry and BiobankK-M Myhr, N Grytten, Ø Torkildsen, et al.
Acta Neurologica Scandinavica. Supplementum|January 3, 2013
A need for national registries and international collaborative research in multiple sclerosisK M Myhr, N Grytten, Ø Torkildsen, et al.
Journal of Neurology|December 14, 2023
Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based studyA Habbestad, J S Willumsen, J H Aarseth, et al.
European Journal of Neurology|February 8, 2005
IL-10 promoter haplotype influence on interferon treatment response in multiple sclerosisS Wergeland, A Beiske, H Nyland, et al.
Acta Neurologica Scandinavica|June 4, 2015
WT1 and interferon-β-vitamin D association in MS: a longitudinal studyT Holmøy, Q Y Esbensen, Ø Torkildsen, et al.
European Journal of Neurology|March 22, 2016
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patientsS Wergeland, K-M Myhr, K I Løken-Amsrud, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 15, 2015
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre studyJ Kuhle, G Disanto, R Dobson, et al.
Pageof 1